Cresco Labs Inc., one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Joe Caltabiano has advised the Company of his decision to resign from the position of President effective immediately.
Medicine Man Technologies Inc. announced today that Andy Williams, president and vice chairman of the Board, has decided to leave the Company to focus on cannabis medical and genetic research, along with pursuing new opportunities in the cannabis industry.
Aurora Cannabis Inc., the Canadian company defining the future of cannabis worldwide, today appointed two new independent directors, Lance Friedmann and Michael Detlefsen (together the "New Directors"). The New Directors term begins immediately.
Aurora Cannabis Inc., the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this afternoon. The Company also announced a business transformation plan that better aligns SG&A expenses, and capital expenditures with current market conditions.
Sundial Growers Inc. announces certain changes to its executive team and board of directors as described below. Torsten Kuenzlen has resigned as the Company's Chief Executive Officer and will step down as a director, effective immediately, to pursue other interests.
TerrAscend Corp., the first and only global cannabis company licensed for sales in Canada, the U.S., and the EU, today announced the termination of the Securities Purchase Agreement pursuant to which TerrAscend would have acquired all of the issued and outstanding equity interests of Gravitas Nevada Ltd., a vertically-integrated cannabis business in Nevada.
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announces the expansion of its global senior leadership team with two strategic hires: Jon Levin as Chief Operating Officer, who was formerly with Revlon, and Michael Kruteck as Chief Financial Officer, who was formerly with Molson Coors and Pharmaca.
Aphria Inc. today reported its results for the second quarter ended November 30, 2019. All amounts are expressed in thousands of Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts. The Company also announced that Irwin D. Simon, will officially remove “interim” from his title, effective today.